CIK 0001607678
- Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461073877
- Phone
- +1 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 4 Planned sale Director sold 25,000 shares at $28.05 ($701,250)
- 4 Planned sale President & CEO sold 85,000 shares at an average $24.71 ($2,100,750)
- 4 Planned sale President & CEO sold 35,000 shares at $23.95 ($838,250)
- 4 Planned sale Director sold 30,000 shares at $23.05 ($691,500)
- 4 Shares withheld for taxes President & CEO gave up 254,192 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 63,409 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 15,000 shares at $17.90 ($268,500)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 40,000 shares at $25.00 ($1,000,000)
- 4 Open-market sale Director sold 16,000 shares at $24.00 ($384,000)
- 4 Open-market sale President & CEO sold 45,000 shares at $22.45 ($1,010,250)
- 4 Open-market sale Director sold 16,000 shares at $22.00 ($352,061)
- 4 Open-market sale President & CEO sold 35,000 shares at $21.45 ($750,750)
- 4 Open-market sale Director sold 20,786 shares at $20.00 ($415,720)
- 4 Open-market sale President & CEO sold 155,000 shares at $20.45 ($3,169,766)
- 4 Open-market sale Chief Operating Officer sold 12,500 shares at $20.00 ($250,000)
Page 4 of 11 · 216 filings